Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002777
Filing Date
2008-03-14
Accepted
2008-03-14 14:42:55
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183624z10-k.htm 10-K 965567
2 EXHIBIT 10.28 a2183624zex-10_28.htm EX-10.28 110245
3 EXHIBIT 21.1 a2183624zex-21_1.htm EX-21.1 1807
4 EXHIBIT 23.1 a2183624zex-23_1.htm EX-23.1 2931
5 EXHIBIT 31.1 a2183624zex-31_1.htm EX-31.1 7160
6 EXHIBIT 31.2 a2183624zex-31_2.htm EX-31.2 7151
7 EXHIBIT 32.1 a2183624zex-32_1.htm EX-32.1 4051
8 EXHIBIT 32.2 a2183624zex-32_2.htm EX-32.2 4052
9 G78652LCI001.JPG g78652lci001.jpg GRAPHIC 3656
10 G796714.JPG g796714.jpg GRAPHIC 25920
  Complete submission text file 0001047469-08-002777.txt   1145467
Mailing Address 7 GRAPHICS DRIVE EWING NJ 08628
Business Address 7 GRAPHICS DRIVE EWING NJ 08628 609 637-9700
Redpoint Bio CORP (Filer) CIK: 0001328003 (see all company filings)

EIN.: 203215854 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51708 | Film No.: 08689037
SIC: 8731 Services-Commercial Physical & Biological Research